Quarterly report · Q2
4572.TEDINET S100RGZ5
Period2023-01-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥501m | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥1.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥840m | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥864m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥312m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥868m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥306m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥869m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥349m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥886m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥359m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥886m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥359m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥4.6bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥4.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥5.2bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥453m | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥625m | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.1bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥939m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥708m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥585m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥126m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥57m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥367m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥166m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-53.81 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.46 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-99.1 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-26.53 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.25 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.9% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.7% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 10
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥1.0bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥501m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥501m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥169m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥286m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥286m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥547m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥553m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥553m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥235m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 424
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)西 方 実 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)安 場 達 哉 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 839543000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 500570000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1386748000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -306431000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -868405000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -1278820000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -359120000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -885608000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -1349539000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -236098000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -861390000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -1331861000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 4425947000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 4111801000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 3641844000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 5218214000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 4565118000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 4266453000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -26.53 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -53.81 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -99.10 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.847 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.899 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.850 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 585341000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -938544000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -708390000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -57309000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -6854000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -125696000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 166348000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 1222158000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 367006000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 4684699000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 3684625000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3379048000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | -25.25 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -21.46 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17101900 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17101900 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 17101900 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17101900 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |